INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

07 Aug 2024 07:40:54 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

07 Aug 2024 07:30:38 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

24 Jul 2024 08:00:01 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

18 Jun 2024 07:30:16 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10 Jun 2024 08:00:34 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

29 May 2024 08:00:54 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

23 May 2024 08:00:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

08 May 2024 08:00:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

07 May 2024 07:30:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

30 Apr 2024 08:00:53 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

24 Apr 2024 16:01:19 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Prices Public Offering of Common Stock

17 Apr 2024 20:46:08 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

16 Apr 2024 16:06:34 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

16 Apr 2024 09:45:25 By NetDania Notify

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

16 Apr 2024 07:00:53 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

28 Mar 2024 09:47:48 By NetDania Notify

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

19 Mar 2024 08:30:38 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

06 Mar 2024 08:00:20 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference

27 Feb 2024 08:00:35 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update

22 Feb 2024 07:30:17 By Nasdaq GlobeNewswire